- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY 3.90 Å
 - Oligo State
 - homo-trimer
 - Ligands
 - 19 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
 - 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
 NAG-NAG-FUC.6: 3 residues within 4Å:- Chain A: A.699, E.1065, N.1067
 
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:A.699
 
NAG-NAG-FUC.16: 4 residues within 4Å:- Chain B: A.699, E.1065, K.1066, N.1067
 
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:A.699
 
NAG-NAG-FUC.26: 3 residues within 4Å:- Chain C: A.699, E.1065, N.1067
 
No protein-ligand interaction detected (PLIP)- 6 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
 NAG-NAG-MAN.7: 4 residues within 4Å:- Chain A: N.1091, T.1093, H.1094, F.1096
 
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.8: 2 residues within 4Å:- Chain A: I.1125, N.1127
 
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.17: 4 residues within 4Å:- Chain B: N.1091, T.1093, H.1094, F.1096
 
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:F.1096
 
NAG-NAG-MAN.18: 1 residues within 4Å:- Chain B: N.1127
 
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.27: 4 residues within 4Å:- Chain C: N.1091, T.1093, H.1094, F.1096
 
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:F.1096
 
NAG-NAG-MAN.28: 1 residues within 4Å:- Chain C: N.1127
 
No protein-ligand interaction detected (PLIP)- 26 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
 NAG.29: 2 residues within 4Å:- Chain A: Y.28, N.61
 
Ligand excluded by PLIPNAG.30: 5 residues within 4Å:- Chain A: N.122, T.124, N.125, V.127, E.154
 
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain A: K.147, N.149, S.151
 
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain A: E.132, N.165
 
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain A: N.273, N.275, T.277
 
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain A: N.336, V.360
 
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain A: N.596
 
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain A: N.650
 
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain A: N.702
 - Chain B: D.789
 
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain A: N.1151
 
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain B: Y.28, N.61
 
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain B: K.147, N.148, N.149
 
Ligand excluded by PLIPNAG.41: 1 residues within 4Å:- Chain B: N.234
 
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain B: N.324, T.326, Q.573
 
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain B: G.332, N.336
 
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain B: T.300, N.596
 
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain B: H.648, V.649, N.650
 
Ligand excluded by PLIPNAG.46: 3 residues within 4Å:- Chain B: N.702, G.1124
 - Chain C: D.789
 
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain B: N.1151
 
Ligand excluded by PLIPNAG.48: 2 residues within 4Å:- Chain C: Y.28, N.61
 
Ligand excluded by PLIPNAG.49: 2 residues within 4Å:- Chain C: Y.145, N.149
 
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain C: N.324, P.572, Q.573
 
Ligand excluded by PLIPNAG.51: 1 residues within 4Å:- Chain C: N.596
 
Ligand excluded by PLIPNAG.52: 1 residues within 4Å:- Chain C: N.650
 
Ligand excluded by PLIPNAG.53: 2 residues within 4Å:- Chain A: D.789
 - Chain C: N.702
 
Ligand excluded by PLIPNAG.54: 2 residues within 4Å:- Chain C: Y.1148, N.1151
 
Ligand excluded by PLIP- Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Xing, X. et al., Structures of SARS-CoV-2 spike protein alert noteworthy sites for the potential approaching variants. Virol Sin (2022)
          


 - Release Date
 - 2023-09-06
 - Peptides
 - Spike glycoprotein: ABC
 - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
AB
BC
C 
- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY 3.90 Å
 - Oligo State
 - homo-trimer
 - Ligands
 - 19 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
 - 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
 - 6 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
 - 26 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
 - Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Xing, X. et al., Structures of SARS-CoV-2 spike protein alert noteworthy sites for the potential approaching variants. Virol Sin (2022)
          


 - Release Date
 - 2023-09-06
 - Peptides
 - Spike glycoprotein: ABC
 - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
AB
BC
C